Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michels RE"'
Publikováno v:
In Value in Health October 2018 21 Supplement 3:S339-S340
Autor:
Michels RE; IQVIA, Real World Solutions, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. renee_michels@hotmail.com., Arteaga CH; HEOR Value Hub, Med-I-Mart BVBA/SPRL, Helshovenstraat 23, 3840, Hoepertingen, Belgium., Peters ML; IQVIA, Real World Solutions, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Krol M; IQVIA, Real World Solutions, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands.
Publikováno v:
Applied health economics and health policy [Appl Health Econ Health Policy] 2022 Sep; Vol. 20 (5), pp. 717-729. Date of Electronic Publication: 2022 Jul 18.
Autor:
Michels RE; Department of Real World & Analytics Solutions, IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands., Peters ML; Department of Real World & Analytics Solutions, IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands., Schiffers KM; Merck B.V., an affiliate of Merck KGaA, Darmstadt, Germany, Tupolevlaan 61, 1119 NW, Schiphol-Rijk, The Netherlands., Bouma PA; Department of Neurology, Tergooi Ziekenhuis, van Riebeeckweg 212, 1213 XZ, Hilversum, The Netherlands., Hengstman GI; Department of Neurology, Catharina Ziekenhuis, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands., van Munster CE; Department of Neurology, Amphia Ziekenhuis, Molengracht 21, 4818 CK, Breda, The Netherlands., Zeinstra E; Department of Neurology, Isala, Hoogeveenseweg 38, 7943 KA, Meppel, The Netherlands., Voer G; Merck B.V., an affiliate of Merck KGaA, Darmstadt, Germany, Tupolevlaan 61, 1119 NW, Schiphol-Rijk, The Netherlands., Krol M; Department of Real World & Analytics Solutions, IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2021 Feb; Vol. 10 (2), pp. 93-100. Date of Electronic Publication: 2020 Dec 04.
Autor:
Michels RE; IQVIA, Real World Evidence Solutions, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands., De Francesco M; IQVIA, Real World Insights, Da Vincilaan 7, 1930, Zaventem, Belgium., Mahajan K; IQVIA, Real World Insights, Gurgaon, India., Hengstman GJD; Department of Neurology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands., Schiffers KMH; Merck B.V., Tupolevlaan 41-61, 1119 NW, Schiphol-Rijk, The Netherlands., Budhia S; PAREXEL International, PAREXEL Access Consulting, London, UK., Harty G; EMD Serono, a business of Merck KGaA, Boston, MA, USA., Krol M; IQVIA, Real World Evidence Solutions, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. Marieke.Krol@iqvia.com.
Publikováno v:
Applied health economics and health policy [Appl Health Econ Health Policy] 2020 Feb; Vol. 18 (1), pp. 141.
Autor:
Michels RE; IQVIA, Real World Evidence Solutions, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands., de Fransesco M; IQVIA, Real World Insights, Da Vincilaan 7, 1930, Zaventem, Belgium., Mahajan K; IQVIA, Real World Insights, Gurgaon, India., Hengstman GJD; Department of Neurology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands., Schiffers KMH; Merck B.V., Tupolevlaan 41-61, 1119 NW, Schiphol-Rijk, The Netherlands., Budhia S; PAREXEL International, PAREXEL Access Consulting, London, UK., Harty G; EMD Serono, a business of Merck KGaA, Boston, MA, USA., Krol M; IQVIA, Real World Evidence Solutions, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. mkrol@iqvia.com.
Publikováno v:
Applied health economics and health policy [Appl Health Econ Health Policy] 2019 Dec; Vol. 17 (6), pp. 857-873.